Tarek Mansour - Montreal, CA Allan H.L. Tse - San Francisco CA
Assignee:
BioChem Pharma Inc. - Laval
International Classification:
A61K 3170 A01N 4304 C07H 1900
US Classification:
514 49
Abstract:
The present invention is directed to a method of treating hepatitis B viral infections in mammals comprising the administration of. beta. -L-5-fluoro-2',3'-dideoxycytidine and pharmaceutically acceptable derivatives thereof.